{"schema_version":"1","generated_at":"2026-11-01T09:45:47.061Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kerry-rogers","json_url":"https://www.findmykol.com/kol/kerry-rogers/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kerry-rogers","name":"Kerry Rogers","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"city":"Columbus","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1659534246","openalex":"A5061189442"},"summary":"Kerry Rogers is a Hematology physician. OpenAlex indexes 14 publications with 261 citations (h-index 7); ClinicalTrials.gov lists 10 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":14,"cited_by_count":261,"h_index":7,"latest_activity_year":2025,"source":"works"},"trials":{"count":10,"shown":3,"withheld":7,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07734038","title":"Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"Kerry Rogers","source_url":"https://clinicaltrials.gov/study/NCT07734038","trial_url":"https://www.findmykol.com/trial/NCT07734038"},{"nct":"NCT06466122","title":"Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Kerry Rogers","source_url":"https://clinicaltrials.gov/study/NCT06466122","trial_url":"https://www.findmykol.com/trial/NCT06466122"},{"nct":"NCT05336812","title":"Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Ohio State University Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT05336812","trial_url":"https://www.findmykol.com/trial/NCT05336812"}],"source":"trials"},"payments":{"company_count":16,"program_years":{"first":2021,"last":null},"rows_total":38,"shown":3,"withheld":35,"rows":[{"payer":"BeiGene USA, Inc.","program_year":2025,"amount_usd":4800,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1659534246"},{"payer":"Lilly USA, LLC","program_year":2025,"amount_usd":4533,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1659534246"},{"payer":"AstraZeneca UK Limited","program_year":2025,"amount_usd":3767.5,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1659534246"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1659534246","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":90.4,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":70.6,"drugs":[{"name":"Calquence","share_pct":43.5},{"name":"Imbruvica","share_pct":25.8},{"name":"Jaypirca","share_pct":15.9},{"name":"Brukinsa","share_pct":14.8}],"max_beneficiaries":null},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":19.8,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":11}]},{"area":"Anti-infectives","share_pct":6.5,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":6.5,"drugs":[{"name":"Valacyclovir","share_pct":100}],"max_beneficiaries":12}]},{"area":"Musculoskeletal","share_pct":3.1,"classes_total":1,"classes":[{"class":"Xanthine oxidase inhibitor","setting":"prescribed","share_pct":3.1,"drugs":[{"name":"Allopurinol","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":84.3,"facility_pct":15.7},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2021,"last":2025},"rows_total":5,"shown":3,"withheld":2,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA177292","title":"Targeted Therapies for Lymphoid Malignancies","fiscal_year":2025,"amount_usd":"538241","organization":"OHIO STATE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA177292"},{"project":"R01CA177292","title":"Targeted Therapies for Lymphoid Malignancies","fiscal_year":2024,"amount_usd":"511329","organization":"OHIO STATE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA177292"},{"project":"R01CA177292","title":"Targeted Therapies for Lymphoid Malignancies","fiscal_year":2023,"amount_usd":"527476","organization":"OHIO STATE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA177292"}],"source":"grants"},"contact":{"address_1":"460 W 10TH AVE FL 5","city":"Columbus","state":"OH","zip":"432101240","phone":"614-293-3196","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1659534246","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":7,"payments":35,"funding":2}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-12-16","provider_certified":"2024-12-16","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}